Extracellular matrix remodelling in the endometrium and its possible relevance to the pathogenesis of endometriosis

Human Reproduction Update

Volumn 4, Issue 5, 1998, Pages 730-735

  Sillem, M ^a   Prifti, S ^b   Neher, M ^b   Runnebaum, B ^b  

^a DEUTSCHE KLINIK FÜR DIAGNOSTIK   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Endometriosis; Endometrium; Extracellular matrix; Pathogenesis; Secreted proteases

Indexed keywords

GESTAGEN; MESSENGER RNA; METALLOPROTEINASE; PLASMINOGEN ACTIVATOR INHIBITOR; PROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 3; UROKINASE RECEPTOR;

CONFERENCE PAPER; CONTROLLED STUDY; ENDOMETRIOSIS; ENDOMETRIUM; ENDOMETRIUM CELL; EXTRACELLULAR MATRIX; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MENSTRUATION; PATHOGENESIS; PRIORITY JOURNAL;

CELLS, CULTURED; ENDOMETRIOSIS; ENDOMETRIUM; ENDOPEPTIDASES; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION REGULATION; HUMANS; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLASMINOGEN ACTIVATOR INHIBITOR 2; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TRANSCRIPTION, GENETIC; URINARY PLASMINOGEN ACTIVATOR;

EID: 0032406407     PISSN: 13554786     EISSN: None     Source Type: Journal    
DOI: 10.1093/humupd/4.5.730     Document Type: Conference Paper

References (27)

1. Al Roof Higazi, A., Mazar, A., Wang, J. et al. (1996) Single-chain, urokinase-type plasminogen activator bound to its receptor is relatively resistant to plasminogen activator inhibitor type 1. Blood, 87, 3545-3549.
2. Bartosik, D., Jacobs, S.L. and Kelly, L.J. (1986) Endometrial tissue in peritoneal fluid. Fertil. Steril., 46, 796-800.
3. Bertaux, B., Hornebeck, W., Eisen, A.Z. et al. (1991) Growth stimulation of human keratinocytes by tissue inhibitor of metalloproteinases. J. Invest. Dermatol., 97, 679-685.
4. Bjorn, S.F., Hastrup, N., Lund, L.R. et al. (1997) Co-ordinated expression of MMP-2 and its putative activator, MT1-MMP, in human placentation. Mol. Hum. Reprod., 3, 713-723.
5. Blumenkrantz, M.J., Gallagher, N. and Bashore, R.A. (1981) Retrograde menstruation in women undergoing chronic peritoneal dialysis. Obstet. Gynecol., 57, 667-670.
6. Casey, J.R., Petranka, J.G., Kottra, J. et al. (1994) The structure of the urokinase-type plasminogen activator receptor gene. Blood, 84, 1151-1156.
7. Casslèn, B., Nordengren, J., Gustavsson, B. et al. (1995) Progesterone stimulates degradation of urokinase plasminogen activator in endometrial stromal cells by increasing its inhibitor and surface expression of the u-PA receptor. J. Clin. Endocrinol., Metab., 80, 2776-2784.
8. Chavira, R., Burnett, T.J. and Hageman, J.H. (1984) Assaying proteinases with Azocoll. Anal. Biochem., 136, 446-450.
9. Halme, J., Hammond, M.G. and Hulka, J.F. (1984) Retrograde menstruation in healthy women and in patients with endometriosis. Obstet. Gynecol., 64, 141-154.
10. Hayakawa, T., Yamashita, K., Ohuchi, E. et al. (1994) Cell growth-promoting activity of tissue inhibitor of metalloproteinases-2 (TIMP-2). J. Cell Sci., 107, 2373-2379.
11. Hulboy, D.L., Rudolph, L.A. and Matrisian, L.M. (1997) Matrix metalloproteinases as mediators of reproductive function. Mol. Hum. Reprod, 3, 27-45.
12. Leyendecker, G., Kunz, G., Wildt, L. et al. (1996) Uterine hyperperistalsis and dysperistalsis as dysfunctions of the mechanism of rapid sperm transport in patients with endometriosis and infertility. Hum. Reprod., 11, 1542-1551.
13. Littlefield, B.A. (1991) Plasminogen activators in endometrial physiology and embryo implantation. A review. Ann. N.Y. Acad. Sci., 622, 166-175.
14. Mignatti, P. and Rifkin, D.B. (1993) Biology and biochemistry of proteinases in tumor invasion. Physiol. Rev., 73, 161-195.
15. Mizukami, I.F., Faulkner, N.E., Gyetko, M.R. et al. (1995) Enzyme-linked immunosorbent assay detection of a soluble form of urokinase plasminogen activator receptor in vivo. Blood, 86, 203-211.
16. Mohanam, S., Sawaya, R., McCutcheon, I. et al. (1993) Modulation of in vitro invasion of human glioblastoma cells by urokinase-type plasminogen activator receptor antibody. Cancer Res., 53, 4143-4147.
17. Nemeth, J.A. and Goolsby, C.L. (1993) TIMP-2, a growth-stimulatory protein from SV40-transformed human fibroblasts. Exp. Cell Res., 207, 376-382.
18. Okhuysen, P.C., Chappell, C.L., Kettner, C. et al. (1996) Cryptosporidium parvum metalloaminopeptidase inhibitors prevent in vitro excystation. Antimicrob. Agents Chemother., 40, 2781-2784.
19. Saito, T., Mizumoto, K., Kuroki, K. et al. (1995) Expression of MMP 3 and TIMP-1 in the endometriosis and the influence of danazol. Acta Obstet. Gynaecol. Jpn., 47, 495-196.
20. Sampson, J.A. (1925) Heterotopic or misplaced endometrial tissue. Am. J. Obstet. Gynecol., 10, 649-664.
21. Schatz, F. and Lockwood, C.J. (1993) Progestin regulation of plasminogen activator inhibitor type 1 in primary cultures of endometrial stromal and decidual cells. J. Clin. Endocrinol. Metab., 77, 621-625.
22. Sillem, M., Hahn, U., Coddington, C.C. et al. (1996) Ectopic growth of endometrium depends on its structural integrity and proteolytic activity in the cynomolgus monkey (Macaca fascicularis) model of endometriosis. Fertil. Steril., 66, 468-473.
23. Spuijbroek, M.D.E.H., Dunselman, G.A.J., Menheere P.P.C.A. et al. (1991) Early endometriosis invades the extracellular matrix. Fertil. Steril., 58, 929-933.
24. Tabibzadeh, S. (1996) The signals and molecular pathways involved in human menstruation, a unique process of tissue destruction and remodelling. Mol. Hum. Reprod., 2, 77-92.
25. Wei, Y., Lukashev, M., Simon, D.I. et al. (1996) Regulation of integrin function by the urokinase receptor. Science, 273, 1551-1555.
26. Woessner, J.F. (1991) Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J., 5, 2145-2154.
27. Zhang, J. and Salamonsen, L.A. (1997) Tissue inhibitor of metalloproteinases (TIMP) -1, -2 and -3 in human endometrium during the menstrual cycle. Mol. Hum. Reprod., 3, 735-741.